University of Cincinnati

Scripps appoints new president and CEO of the Scripps Howard Fund

Retrieved on: 
星期二, 五月 7, 2024
E. W. Scripps Company, University, West Virginia University, Cincinnati metropolitan area, Indiana University–Purdue University Indianapolis, Certification, Literacy, Partnership, SSP, United Way, Retirement, Reed College, Journalism, Fund, Child, University of Cincinnati, Management

CINCINNATI, May 7, 2024 /PRNewswire/ -- Meredith Delaney has been appointed president and CEO of the Scripps Howard Fund, the philanthropic arm of The E.W.

Key Points: 
  • CINCINNATI, May 7, 2024 /PRNewswire/ -- Meredith Delaney has been appointed president and CEO of the Scripps Howard Fund, the philanthropic arm of The E.W.
  • Delaney currently serves as director of philanthropic strategies for the Scripps Howard Fund, a public charity that supports philanthropic and journalism causes important to Scripps.
  • I am confident that the Scripps Howard Fund will be in good hands – continuing to create informed and engaged communities across the country."
  • Delaney has helped the Fund serve Scripps' employees and local television stations with the launch of the Community Impact Campaign and Disaster Relief initiatives.

Life Time Appoints James LaValle Chief Science Officer

Retrieved on: 
星期一, 四月 29, 2024
American Academy, Organization, University, Lavalle, Book, University of Cincinnati, Health, Étienne-Émile Baulieu, LTH, Weight loss, Partnership, Research, Obesity, Nursing, College, Metabolism, Movement, Peptide, The College of Medicine, Aesthetics, Longevity

CHANHASSEN, Minn., April 29, 2024 /PRNewswire/ -- Life Time (NYSE: LTH) today announced the appointment of James LaValle, clinical pharmacist, C.C.N.M.T. as Chief Science Officer. LaValle will spearhead the development and implementation of scientific initiatives and strategic relationships to support MIORA, Life Time's new longevity and performance program launched in late 2023, including the first dedicated MIORA clinic at Life Time Target Center in Minneapolis.

Key Points: 
  • CHANHASSEN, Minn., April 29, 2024 /PRNewswire/ -- Life Time (NYSE: LTH) today announced the appointment of James LaValle, clinical pharmacist, C.C.N.M.T.
  • as Chief Science Officer.
  • LaValle will spearhead the development and implementation of scientific initiatives and strategic relationships to support MIORA , Life Time's new longevity and performance program launched in late 2023, including the first dedicated MIORA clinic at Life Time Target Center in Minneapolis.
  • Building and enhancing new partnerships with the American Academy of Anti-Aging Medicine, International Peptide Society, and other leading organizations in the space.

Dr. Anthony Fletcher Installed as President of the Association of Black Cardiologists

Retrieved on: 
星期二, 四月 23, 2024
Education, Xavier University, George Washington University Hospital, University, Blood, ABC, University of Cincinnati, Heart, Capacity building, Chairperson, Doctor of Philosophy, FACC, Cardiology, Cardiovascular disease, MBA, Internal medicine, ABC Board

WASHINGTON, April 23, 2024 /PRNewswire/ -- The Association of Black Cardiologists (ABC) proudly announces it 20th President, Dr. Anthony Fletcher.

Key Points: 
  • WASHINGTON, April 23, 2024 /PRNewswire/ -- The Association of Black Cardiologists (ABC) proudly announces it 20th President, Dr. Anthony Fletcher.
  • He is an interventional cardiologist with CHI St. Vincent Cardiology and Medicine Clinic in Little Rock, Arkansas.
  • Dr. Fletcher is a graduate of Xavier University in Cincinnati, Ohio, and the University of Cincinnati College of Medicine.
  • During his presidency, Dr. Fletcher is committed to forging the mission and vison of the ABC by ensuring inclusivity and diversity for all.

Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting

Retrieved on: 
星期五, 四月 12, 2024
Real-World Evidence, Continuity, American Academy, University, FAAN, Parkinson's disease, Randomness, State university system, Abstract, Research, Spirometry, MDT, ALS, Movement disorder, AAN, Disease, MTPA, Control, Data mart, Boundless, Annual general meeting, ISR, University of Cincinnati, Session 9, Knowledge, Pharmaceutical industry

JERSEY CITY, N.J., April 12, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced seven presentations will be shared at the American Academy of Neurology (AAN) 2024 Annual Meeting being held in Denver, Colo., Apr.13-18, 2024.

Key Points: 
  • JERSEY CITY, N.J., April 12, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced seven presentations will be shared at the American Academy of Neurology (AAN) 2024 Annual Meeting being held in Denver, Colo., Apr.13-18, 2024.
  • The presentations will discuss four abstracts in Parkinson's disease (PD) and three in amyotrophic lateral sclerosis (ALS).
  • Data from the BouNDless subgroup analysis will be presented orally during a Scientific Platform Session at the meeting.
  • ; State University of New York Upstate Medical University)
    Poster Session 6 (#11-013): 8:00 – 9:00 a.m. MDT, April 16

Institute for Supply Management® Announces 2024 R. Gene Richter Scholarship Winners

Retrieved on: 
星期四, 三月 28, 2024
Organization, University, Stanley Black, Memory, Wayne State University, Hewlett-Packard, University of Cincinnati, IBM, University of South Carolina, Student, Pennsylvania State University, Creativity, ISM, Stanley Black & Decker, Management

TEMPE, Ariz., March 28, 2024 /PRNewswire/ -- Institute for Supply Management® (ISM®) has selected the 2024 recipients of the R. Gene Richter Scholarship, an award presented annually to the top supply management students from across the United States. Recipients were determined based upon a submitted essay, cumulative grade point average, demonstrated leadership, extracurricular involvement, and overall achievements as an undergraduate professional, including through internships and case competitions.

Key Points: 
  • TEMPE, Ariz., March 28, 2024 /PRNewswire/ -- Institute for Supply Management® (ISM®) has selected the 2024 recipients of the R. Gene Richter Scholarship, an award presented annually to the top supply management students from across the United States.
  • We truly believe they will grow to become leaders in supply management," said Nancy Richter, founder of the R. Gene Richter Scholarship Program.
  • The R. Gene Richter Scholarship Program was established and named in memory of R. Gene Richter, who was a galvanizing force in the field of procurement.
  • For information on the R. Gene Richter Scholarship Program and the 2024 winners, visit: richterfoundation.org , and ismworld.org/awards .

ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination

Retrieved on: 
星期三, 三月 6, 2024
Infection, Bangladesh Technical Education Board, CD4, Superior, Hepatitis B, Headache, CpG, Fungal infection, NIAID, CROI, ACTG, University of Cincinnati, Weill Cornell Medicine, Conference, Vaccination, University, ART, Fatigue, Virus, Myalgia, White, Black, Protocol, UM1, Massachusetts General Hospital, Male, Hepatitis, HIV, University of North Carolina, Vaccine

These data demonstrated that the HepB-CpG vaccine achieved up to 99 percent protection among people living with HIV who had previously not responded to conventional hepatitis B vaccines, a noteworthy increase compared to the protection achieved by conventional vaccines.

Key Points: 
  • These data demonstrated that the HepB-CpG vaccine achieved up to 99 percent protection among people living with HIV who had previously not responded to conventional hepatitis B vaccines, a noteworthy increase compared to the protection achieved by conventional vaccines.
  • People living with HIV, especially those with lower CD4 counts, often do not develop protective antibodies after receiving conventional hepatitis B vaccines.
  • The HepB-CpG (HEPLISAV-B®) vaccine includes a TLR-9 agonist adjuvant (CpG 1018® adjuvant) and is known to achieve high protection against hepatitis B among people living with HIV, but until now there have been limited data about its protection among people living with HIV who have not responded to conventional hepatitis B vaccines.
  • “Hepatitis B remains a significant issue for people living with HIV, as having both viruses increases the likelihood of liver complications,” said ACTG Chair Judith Currier, M.D., M.Sc., University of California Los Angeles.

Spencer Fane Enters Nation’s Second Largest Legal Market with Patent Litigation Group

Retrieved on: 
星期三, 二月 28, 2024
Wake Forest University, Metallurgy, IAM, University, United States district court, International trade, Culture, District court, West Virginia University, Invention, Smartphone, Virginia University, Patent, University of Cincinnati, Intellectual property, Law, IP, Juris, Telecommunications, Chemical engineering, Semiconductor, Justice, Robotics, Software, Wilfrid Sellars

The trio joins the firm’s growing Intellectual Property practice while also giving Spencer Fane a foothold in the second-largest legal market in the U.S.

Key Points: 
  • The trio joins the firm’s growing Intellectual Property practice while also giving Spencer Fane a foothold in the second-largest legal market in the U.S.
  • The group joins a Spencer Fane IP team that possesses both the technical knowledge and legal experience necessary to protect inventors, entrepreneurs, and businesses of all sizes.
  • She has litigated patent cases for over 20 years, including as co-lead counsel in over ten lawsuits that went to trial.
  • Holley has managed all aspects of patent litigation including pre-filing diligence, claim construction, fact and expert discovery, dispositive motions, and trial.

Universal Display Corporation Announces the Appointment of New Board Members

Retrieved on: 
星期四, 三月 7, 2024
Research, Professional Services, Hardware, Consumer Electronics, Alternative Energy, Apps, Applications, Energy, Technology, Semiconductor, Science, Nanotechnology, Finance, University, Doctor of Philosophy, Biotechnology, Cystic fibrosis, Investment, General partnership, UDC, Health, MBA, Brandywine Realty Trust, OLED, Business, Open University, Rockwell Medical, Organization, Biological engineering, Partner (business rank), University of Cincinnati, Lighting, LLP, Rothschild & Co, BDN, Universal Display Corporation, Management

Universal Display Corporation (Nasdaq: OLED) (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced that Dr. Nigel Brown and Dr. Joan Lau have joined the Company’s Board of Directors, effective March 4, 2024.

Key Points: 
  • Universal Display Corporation (Nasdaq: OLED) (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced that Dr. Nigel Brown and Dr. Joan Lau have joined the Company’s Board of Directors, effective March 4, 2024.
  • The addition of these new directors expands UDC’s Board to ten members.
  • “I am pleased to welcome Nigel and Joan to the Board,” said Steven V. Abramson, President and Chief Executive Officer of Universal Display Corporation and a member of the Board.
  • “Nigel adds a wealth of business innovation, technical knowledge and corporate strategic planning expertise to our Board.

Cincinnati Children's names Bob Carpenter senior vice president and chief legal officer

Retrieved on: 
星期二, 二月 27, 2024
University of Cincinnati, Senior, Liability (financial accounting), Health care, University, History, Hanover College, MD, Risk management, Management

CINCINNATI, Feb. 27, 2024 /PRNewswire/ -- Cincinnati Children's has named Bob Carpenter senior vice president and chief legal officer.

Key Points: 
  • CINCINNATI, Feb. 27, 2024 /PRNewswire/ -- Cincinnati Children's has named Bob Carpenter senior vice president and chief legal officer.
  • "Bob is a trusted leader with proven expertise in corporate governance, risk management, litigation and compliance."
  • An employee of the health system since 2006, Carpenter joins the 11-person Executive Team led by Steve Davis, MD, president and chief executive officer of Cincinnati Children's.
  • He succeeds Rosland Fisher McLeod, who recently left after having been chief legal officer since 2022.

Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA for FDA Approval in Second Half of 2024

Retrieved on: 
星期三, 二月 14, 2024
Fibromyalgia, Tonix Pharmaceuticals, FDA, Pain, Food, Sleep, Behavioral neuroscience, Hope, Hydrogen chloride, University, Fatigue, Patient, University of Cincinnati, University of Michigan, Psychiatry, Tablet, NDA, KOL, Pharmaceutical industry

CHATHAM, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, held a key opinion leader (KOL) webinar to discuss the positive Phase 3 data of Tonmya™ (also known as TNX-102 SL, cyclobenzaprine HCl sublingual tablets) for the management of fibromyalgia, and the path to file for FDA approval in the second half of 2024. The webinar was held on January 31, 2024 and hosted by Alliance Global Partners (A.G.P.).

Key Points: 
  • The webinar was held on January 31, 2024 and hosted by Alliance Global Partners (A.G.P.).
  • As previously announced, Tonix’s second positive Phase 3 study, RESILIENT, met its pre-specified primary endpoint, significantly reducing daily pain compared to placebo (p=0.00005) in participants with fibromyalgia.
  • Tonix plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2024 for Tonmya™ for the management of fibromyalgia.
  • “We are now an important step closer to bringing a new, first-line treatment to fibromyalgia patients that offers broad symptom relief and favorable tolerability for chronic use and adherence.”